Ironwood Pharmaceuticals (NASDAQ: IRWD) net income
Ironwood Pharmaceuticals reported a net profit of $24.0m for fiscal 2025, 2,629.2% more than in fiscal 2024 ($0.9m). Its net margin was 8.1%. Earnings per share were $0.15.
Ironwood Pharmaceuticals's best year of the last 10 was fiscal 2021. The biggest drop was in fiscal 2022, −66.9%. It reported a loss in 4 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $24.0m | +2,629.2% | 8.1% | $0.15 |
| 2024 | $0.9m | — | 0.3% | $0.01 |
| 2023 | −$1,002m | −672.5% | −226.4% | −$6.45 |
| 2022 | $175.1m | −66.9% | 42.6% | $1.13 |
| 2021 | $528.4m | +397.7% | 127.7% | $3.26 |
| 2020 | $106.2m | +393.7% | 27.3% | $0.67 |
| 2019 | $21.5m | — | 5.0% | $0.14 |
| 2018 | −$282.4m | — | −81.5% | −$1.85 |
| 2017 | −$116.9m | — | −39.2% | — |
| 2016 | −$81.7m | — | −29.8% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Ironwood Pharmaceuticals net income compared with its sector
By net income for its latest fiscal year, Ironwood Pharmaceuticals ranks 142nd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Ironwood Pharmaceuticals, 8.1%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 140th | GoodRx | $30.4m | 3.8% |
| 141st | Pennant Group | $29.6m | 3.1% |
| 142nd | Ironwood Pharmaceuticals | $24.0m | 8.1% |
| 143rd | Siga Technologies | $23.3m | 24.6% |
| 144th | Privia Health Group | $22.9m | 1.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Ironwood Pharmaceuticals
- How much did Ironwood Pharmaceuticals earn in fiscal 2025?
- Ironwood Pharmaceuticals reported a net profit of $24.0m for fiscal 2025. In fiscal 2024 it reported a net profit of $0.9m.
- What are the earnings per share of Ironwood Pharmaceuticals?
- They were $0.15 in fiscal 2025, compared with $0.01 in fiscal 2024.
- What is the net margin of Ironwood Pharmaceuticals?
- In fiscal 2025 its net profit was 8.1% of its revenue.
- What was the most profitable year for Ironwood Pharmaceuticals?
- Of its last 10 fiscal years, fiscal 2021, with $528.4m.
- Where does Ironwood Pharmaceuticals rank in its sector by net income?
- It ranks 142nd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Ironwood Pharmaceuticals come from?
- From the annual report (Form 10-K) that Ironwood Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Ironwood Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Ironwood Pharmaceuticals: the Ironwood Pharmaceuticals page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.